Moderna COVID-19 Vaccine Shows Robust Antibody Responses in Young Children
The KidCOVE study is currently evaluating the immunogenicity, safety, and tolerability of the mRNA-1273 vaccine in healthy children.
Diagnosis & Disease Information
COVID-19 Vaccine and Sudden Hearing Loss: Is There a Potential Link?
In a cross-sectional, population-based analysis, researchers examined the potential link between COVID-19 vaccination and the occurrence of sudden sensorineural hearing loss.
FDA Panel to Discuss COVID-19 Vaccine Booster Doses, Variants
The advisory committee intends to discuss updating the composition of COVID-19 vaccines to address variants, as well as the timing and populations for COVID-19 vaccine booster doses.
Evaluating Factors Involved in Willingness to Undergo COVID-19 Vaccination
Three social factors, conspiracy mentality, prosociality, and authoritarianism, were examined by researchers to determine the longitudinal relations between individual willingness to undergo vaccination against COVID-19.
In Vitro Studies Show Veklury Retains Antiviral Activity Against SARS-CoV-2 Variants
To assess in vitro antiviral activity, the study used 2 methods to understand the susceptibility of 10 major SARS-CoV-2 variants to Veklury.
Does Heterologous COVID-19 Vaccination Protect Against Seasonal Coronaviruses?
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Does TNFi Therapy for Psoriatic Arthritis Affect COVID-19 Vaccine Immunogenicity?
Researchers studied the immune response to COVID-19 vaccination in patients with psoriatic arthritis receiving treatment with tumor necrosis factor inhibitors.
Carditis Risk Following BNT162b2 Vaccine Administration
Following reports of carditis associated with COVID-19 vaccination, researchers compared BNT162b2 and CoronaVac to determine their effect on risk for the condition.
Rare Cases of Myocarditis in Adolescents, Young Adults After COVID-19 Vaccination
Elizabeth Profita, MD, and Gerard J. Boyle, MD, FACC, discuss myocarditis in younger populations and how pediatric cardiologists should respond with treatment.
FDA Approves Second COVID-19 Vaccine Spikevax
Findings from an ongoing randomized, placebo-controlled, observer-blind phase 3 trial showed Spikevax was 93.2% effective at preventing COVID-19.
- Loading...
Loading...
Loading... 
Loading...